OxyContin maker Purdue Pharma explored addiction treatment - STAT

OxyContin maker Purdue Pharma explored addiction treatment - STAT

Document: Facing blame for seeding the opioid crisis, Purdue explored its next profit opportunity — treating addiction

By DAVID ARMSTRONG — PROPUBLICA

MIKE REDDY FOR STAT

“It is an attractive market,” Purdue staff wrote about opioid treatment. “Large unmet need for vulnerable, underserved and stigmatized patient population.”

READ MORE